Home / DNMT3A Knockout Cell Lines

DNMT3A Knockout Cell Lines

Gene: DNMT3A

Official Full Name: DNA methyltransferase 3 alphaprovided by HGNC

Gene Summary: CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase that is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes to the cytoplasm and nucleus and its expression is developmentally regulated. [provided by RefSeq, Mar 2016]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO01403 DNMT3A Knockout cell line (HeLa) Human DNMT3A 1:3~1:6 Negative Online Inquiry
KO09625 DNMT3A Knockout cell line (HCT 116) Human DNMT3A 1:2~1:4 Negative Online Inquiry
KO09626 DNMT3A Knockout cell line (HEK293) Human DNMT3A 1:3~1:6 Negative Online Inquiry
KO09627 DNMT3A Knockout cell line (A549) Human DNMT3A 1:3~1:4 Negative Online Inquiry

Background

DNMT3A Gene Knockout Cell Lines are genetically modified cell lines designed to specifically disrupt the expression of the DNMT3A gene, which encodes a vital DNA methyltransferase enzyme involved in establishing and maintaining DNA methylation patterns. These cell lines serve as essential tools for studying the role of DNMT3A in epigenetic regulation, cell differentiation, and development. By employing CRISPR-Cas9 genome editing technology, these knockout lines ensure a precise and efficient elimination of DNMT3A function, allowing researchers to investigate the consequences of its absence on cellular behavior and gene expression profiles.

The primary mechanism of DNMT3A involves the addition of methyl groups to DNA, particularly at cytosine residues in CpG dinucleotides, impacting gene activity and developmental processes. Knockout of this gene can lead to profound insights into various biological processes, including stem cell development, oncogenesis, and neurogenesis. In clinical settings, understanding DNMT3A’s role is critical, as mutations in this gene have been implicated in several hematological malignancies, including acute myeloid leukemia. These cell lines enable researchers to model disease states and identify potential therapeutic targets.

What sets DNMT3A Gene Knockout Cell Lines apart from traditional models is their high specificity and reliability, ensuring reproducibility in research outcomes. Unlike chemical inhibitors or simpler genetic models, these knockout lines allow for comprehensive studies without the confounding effects of partial inhibition or off-target mutations. This makes them an invaluable resource for researchers aiming to develop targeted gene therapies or explore epigenetic alterations in complex diseases.

For researchers and clinicians focusing on epigenetics and cancer research, these cell lines provide an unsurpassed advantage in elucidating the fundamental roles of DNMT3A in genomic regulation. The ability to directly manipulate the DNMT3A gene offers a powerful approach to not only understand the basic biology but also develop novel strategies for intervention.

Our company is dedicated to providing high-quality biological tools for cutting-edge research and is committed to supporting the scientific community with products that enable breakthrough discoveries. With years of expertise in genetic engineering, we ensure that our DNMT3A Gene Knockout Cell Lines meet the highest standards for reliability and performance, empowering scientists to advance their studies with confidence.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.